Improving the Assessment of Hypersomnolence

Sponsor
University of Wisconsin, Madison (Other)
Overall Status
Completed
CT.gov ID
NCT02884505
Collaborator
(none)
132
1
22.1
6

Study Details

Study Description

Brief Summary

The overall purpose of this study is to employ a pragmatic, multidimensional assessment of hypersomnolence that "piggybacks" on routine clinical care in patients with suspected disorders of central nervous system (CNS) hypersomnia, to determine whether these additional objective and subjective assessments are useful in the diagnosis and management of these patients.

Condition or Disease Intervention/Treatment Phase
  • Device: Pupillometry
  • Behavioral: Psychomotor Vigilance Task
  • Other: Auditory Evoked Potential
  • Behavioral: Hypersomnia Severity Index

Study Design

Study Type:
Observational
Actual Enrollment :
132 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Improving the Assessment of Hypersomnolence
Actual Study Start Date :
Aug 25, 2017
Actual Primary Completion Date :
Jun 30, 2019
Actual Study Completion Date :
Jun 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Patients with Hypersomnolence

Patients referred for polysomnography and multiple sleep latency test

Device: Pupillometry
Measures pupillary dynamics in darkness and light conditions

Behavioral: Psychomotor Vigilance Task
Response time task measuring neurobehavioral alertness

Other: Auditory Evoked Potential
Measure of electroencephalographic response to standardized auditory tones

Behavioral: Hypersomnia Severity Index
Self-report measure of hypersomnolence

Outcome Measures

Primary Outcome Measures

  1. Proportion of Patients Categorized with Hypersomnolence [2 Years]

    Multiple measurements will be aggregated to arrive at the primary outcome of proportion of patients categorized as having hypersomnolence using either standard assessments or standard assessments plus additional novel hypersomnolence measures of pupillometry, psychomotor vigilance task, and auditory evoked potentials. Proportion of patients with hypersomnolence using standard measures will be calculated as number of patients with mean sleep latency (MSL) on multiple sleep latency test (MSLT) <8 minutes divided by total number of patients. Proportion of patients categorized as having hypersomnolence with additional novel hypersomnolence measures will be calculated as the number of patients with MSL<8 minutes, and/or pupillary unrest index (PUI) >8.9 on pupillometry, and/or PVT lapses >3, and/or P300 delay/sleep negativity during auditory evoked potentials divided by total number of patients.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 89 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18-89

  • Referred for polysomnography/multiple sleep latency test at Wisconsin Sleep, the sleep medicine clinic and laboratory of the University of Wisconsin-Madison

Exclusion Criteria:
  • unstable medical condition that, in the opinion of the investigators, would make it unsafe for the subject to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Wisconsin-Madison, Department of Psychiatry Madison Wisconsin United States 53719

Sponsors and Collaborators

  • University of Wisconsin, Madison

Investigators

  • Principal Investigator: David T Plante, MD, University of Wisconsin, Madison

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT02884505
Other Study ID Numbers:
  • 2015-1462
First Posted:
Aug 31, 2016
Last Update Posted:
Aug 22, 2019
Last Verified:
Aug 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 22, 2019